EP2845148A1 — Counting mechanism for a drug delivery device and drug delivery device
Assigned to Sanofi SA · Expires 2015-03-11 · 11y expired
What this patent protects
The present disclosure concerns a counting mechanism (5) for a drug delivery device, comprising a first counting member (103) comprising an interaction element (115), a second counting member (104) comprising engagement elements (124) that are configured to engage with the intera…
USPTO Abstract
The present disclosure concerns a counting mechanism (5) for a drug delivery device, comprising a first counting member (103) comprising an interaction element (115), a second counting member (104) comprising engagement elements (124) that are configured to engage with the interaction element (115) of the first counting member (103), and a separating member (105), wherein the first counting member (103) is moveable relative to the separating member (105) between a first and a second relative position, and the separating member (105) is configured to prevent an engagement of the interaction element (115) with the engagement elements (124) when the first counting member (103) is in the second relative position with respect to the separating member (105). Further, the present disclosure concerns a drug delivery device comprising said counting mechanism (5).
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.